|
Sign In to gain access to subscriptions and/or personal tools.
|
ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease
Carl Erik Mogensen
Aarhus University Hospitals, DK-8000 Aarhus, Denmark, cem@ afdm.au.dk
Key Words: diabetic nephropathy • microalbuminuria • ACE inhibition • AT-receptor blockade • glomerulopathy • hypertension • blood pressure • macrovascular disease • diabetes mellitus
References
- Lundbæk K. Diabetic angiopathy, a specific vascular disease. Lancet 1954; 1: 377-9.[Medline]
[Order article via Infotrieve]
- Mogensen CE Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. In Mogensen CE (ed.) The Kidney and Hypertension in Diabetes Mellitus, 5th ed. Boston, Dordrecht, London. Kluwer Academic Publishers, 2000: 655-706.
- Mogensen CE Combined high blood pressure and glucose in type 2 diabetes: Double Jeopardy. BMJ 1998; 317:693-4.[Free Full Text]
- The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. New Engl J Med 2000; 342:145-53.[Abstract/Free Full Text]
- Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Diabetes Control and Complications Trial Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-9.[Abstract/Free Full Text]
- UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13.[Abstract/Free Full Text]
- Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 13:1755-62.
- Gæde P., Vedel P., Parving H-H., Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999; 353:617-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Guidelines subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17:151-83.[Web of Science][Medline]
[Order article via Infotrieve]
- Hansson L., Lindholm LH, Niskanen L. et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611-16.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Estacio RO, Jeffers BW, Hiatt WR et al.The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-53.[Abstract/Free Full Text]
- Toumilehto J., Rastenyte D., Birkenhäger W. et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340; 677-84.[Abstract/Free Full Text]
- Hansson L., Lindholm LH, Ekbom T. et al. for the STOP-Hypertension-2 study Group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mogensen CE, Neldam S.,Tikkannen I. et al. for the CALM Study Group. Randomised controlled trial of dual blockade of the renin-angiotensin system in hypertensive, microalbuminuric, non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000. (Submitted for publication)
- Mogensen CE, Christensen CK Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93.[Abstract]
- Mogensen CE, sterby R., Hansen KW, Damsgaard EM Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192-204.[Abstract]
- Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346:1080-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mogensen CE, Vestbo E., Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995; 18: 572-81.[Web of Science][Medline]
[Order article via Infotrieve]
- Viberti GC, Mogensen CE, Groop L., Pauls JF for the European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-9.[Abstract/Free Full Text]
- Laffel LMB, McGill JB, Gans DJ on behalf of the North American Microalbuminuria Study Group.The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. AmJMed 1995; 99:497-504.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Euclid Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349:1787-92.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bojestig M., Karlberg B., Verho M and the Prima Study Group. ACE inhibition during two years did not improve urinary excretion in normotensive microalbuminuric patients. Diabetologia 1998; 41:A544.
- Crepaldi G., Carta Q., Deferrari G. et al. for the Italian Microalbuminuria Study Group in IDDM. Diabetes Care 1998; 21:104-10.[Abstract]
- Mathiesen ER, Hommel E., Hansen HP, Smidt UM, Parving H-H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 1999; 319; 24-5.[Free Full Text]
- Jerums G on behalf of the Melbourne Diabetic Nephropathy Study Group, Melbourne, Australia. ACE inhibition vs. calcium-channel blockade in normotensive type 1 and type 2 diabetic patients with microalbuminuria. Nephrology Dial Trans 1998; 13:1065-66.
- Ebbehøj E., Poulsen PL, Nosadini R., Fioretto R., Fioretto P., Crepaldi C., Mogensen CE Early ACE-I intervention in microalbuminuria: 24h BP, renal function and exercise changes. Abstract of the 34th Annual Meeting of the EASD Barcelona, Spain 8-12 Sept. 1998. Diabetologia 1998; 41(1).
- Rudberg S., sterby R., Bangstad H-J., Dahlquiest G., Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 589-95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hovind P., Rossing P., Tarkow L., Smidt UM, Parving H-H. Progression of diabetic nephropathy. Kidney International (In press).
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 118: 577-81.
- Mogensen CE, Mau Pedersen M., Ebbehøj E. et al. Combination therapy in hypertension-associated diabetic renal disease. Int J Clin Pract suppl. 1997: 52-8.
- Mogensen CE Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285:685-8.[Abstract/Free Full Text]
- Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.[Abstract/Free Full Text]
- Adler AI, Stratton IM, Neil AW et al.Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 3,
234-239 (2000)
DOI: 10.3317/jraas.2000.035
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Coppelli, R. Giannarelli, F. Vistoli, S. Del Prato, G. Rizzo, F. Mosca, U. Boggi, and P. Marchetti
The Beneficial Effects of Pancreas Transplant Alone on Diabetic Nephropathy
Diabetes Care,
June 1, 2005;
28(6):
1366 - 1370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
